Found: 56
Select item for more details and to access through your institution.
miR‐99a‐5p modulates doxorubicin resistance via the COX‐2/ABCG2 axis in triple‐negative breast cancer: from the discovery to in vivo studies.
- Published in:
- Cancer Communications, 2022, v. 42, n. 12, p. 1412, doi. 10.1002/cac2.12352
- By:
- Publication type:
- Article
Serum Phospholipids Fatty Acids and Breast Cancer Risk by Pathological Subtype.
- Published in:
- Nutrients, 2020, v. 12, n. 10, p. 3132, doi. 10.3390/nu12103132
- By:
- Publication type:
- Article
Comparación de escalas pronósticas en pacientes mayores de 65 años intervenidos de meningioma intracraneal. Nuestra experiencia entre 2002-2012 y revisión de la literatura.
- Published in:
- Neurocirugía, 2016, v. 27, n. 1, p. 2, doi. 10.1016/j.neucir.2015.04.003
- By:
- Publication type:
- Article
The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-41472-y
- By:
- Publication type:
- Article
MicroRNA-33b Suppresses Epithelial–Mesenchymal Transition Repressing the MYC–EZH2 Pathway in HER2+ Breast Carcinoma.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01661
- By:
- Publication type:
- Article
High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3601, doi. 10.3390/ijms24043601
- By:
- Publication type:
- Article
Development of a Novel NGS Methodology for Ultrasensitive Circulating Tumor DNA Detection as a Tool for Early-Stage Breast Cancer Diagnosis.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 1, p. 146, doi. 10.3390/ijms24010146
- By:
- Publication type:
- Article
Role of SALL4 in HER2+ Breast Cancer Progression: Regulating PI3K/AKT Pathway.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 21, p. 13292, doi. 10.3390/ijms232113292
- By:
- Publication type:
- Article
Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 15, p. 7812, doi. 10.3390/ijms22157812
- By:
- Publication type:
- Article
Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 19, p. 7427, doi. 10.3390/ijms21197427
- By:
- Publication type:
- Article
Identification of Candidate Polymorphisms on Stress Oxidative and DNA Damage Repair Genes Related with Clinical Outcome in Breast Cancer Patients.
- Published in:
- International Journal of Molecular Sciences, 2012, v. 13, n. 12, p. 16500, doi. 10.3390/ijms131216500
- By:
- Publication type:
- Article
Type does matter. Use VIRGIN olive oil as your preferred fat to reduce your risk of breast cancer: case-control EpiGEICAM study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
APROXIMACIÓN CLÍNICA DE LA TOMA DE DECISIONES SOBRE FERTILIDAD EN PACIENTES DE CÁNCER DE MAMA.
- Published in:
- Psicooncologia, 2010, v. 7, n. 2/3, p. 287
- By:
- Publication type:
- Article
Trajectories of alcohol consumption during life and the risk of developing breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Correlation between trophoblast cell-surface antigen-2 (Trop-2) expression and pathological complete response in patients with HER2-positive early breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 205, n. 3, p. 589, doi. 10.1007/s10549-024-07292-z
- By:
- Publication type:
- Article
Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 201, n. 2, p. 151, doi. 10.1007/s10549-023-07002-1
- By:
- Publication type:
- Article
Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2−) early breast cancer (EBC): results from the GEICAM/2006–10 study.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 177, n. 1, p. 115, doi. 10.1007/s10549-019-05296-8
- By:
- Publication type:
- Article
Clinical implications of routine genomic mutation sequencing in PIK3CA/AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 160, n. 1, p. 69, doi. 10.1007/s10549-016-3980-z
- By:
- Publication type:
- Article
SOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 154, n. 2, p. 351, doi. 10.1007/s10549-015-3616-8
- By:
- Publication type:
- Article
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Frequent Dose Delays and Growth Factor Requirements with the Sequential Doxorubicin-CMF Schedule.
- Published in:
- Acta Oncologica, 1997, v. 36, n. 7, p. 701, doi. 10.3109/02841869709001340
- By:
- Publication type:
- Article
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 12, p. 2355, doi. 10.1002/1878-0261.13141
- By:
- Publication type:
- Article
Optimal [<sup>18</sup>F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain Trial.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266384
- By:
- Publication type:
- Article
Clinicopathological and molecular predictors of [<sup>18</sup>F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 9, p. 2733, doi. 10.1007/s00259-024-06683-0
- By:
- Publication type:
- Article
A Phase II Prospective, Randomized, Double‐Blind, Placebo‐Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor‐Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. 1854, doi. 10.1634/theoncologist.2020-0417
- By:
- Publication type:
- Article
Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-63637-w
- By:
- Publication type:
- Article
Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry).
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-55765-9
- By:
- Publication type:
- Article
Cambios durante la última década en la incidencia y las características de los pacientes politraumatizados en Navarra.
- Published in:
- Emergencias, 2015, v. 27, n. 3, p. 174
- By:
- Publication type:
- Article
Breast Cancer in Very Young Patients in a Spanish Cohort: Age as an Independent Bad Prognostic Indicator.
- Published in:
- Breast Cancer: Basic & Clinical Research, 2019, v. 13, p. N.PAG, doi. 10.1177/1178223419828766
- By:
- Publication type:
- Article
NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-023-02918-4
- By:
- Publication type:
- Article
Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2021.827625
- By:
- Publication type:
- Article
Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-019-14111-3
- By:
- Publication type:
- Article
Clinical Impact of New Treatment Strategies for HER2-Positive Metastatic Breast Cancer Patients with Resistance to Classical Anti-HER Therapies.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4522, doi. 10.3390/cancers15184522
- By:
- Publication type:
- Article
miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 2138, doi. 10.3390/cancers15072138
- By:
- Publication type:
- Article
Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors—Health-EpiGEICAM Study.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4705, doi. 10.3390/cancers14194705
- By:
- Publication type:
- Article
Immunological Landscape of HER-2 Positive Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133167
- By:
- Publication type:
- Article
Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2848, doi. 10.3390/cancers13112848
- By:
- Publication type:
- Article
HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 412, doi. 10.3390/cancers12020412
- By:
- Publication type:
- Article
Additional elevation of the ST segment: a possible early electrocardiographic marker of experimental myocardial reperfusion.
- Published in:
- Cardiovascular Research, 1996, v. 32, n. 6, p. 1141, doi. 10.1016/S0008-6363(96)00161-7
- By:
- Publication type:
- Article
Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens.
- Published in:
- 2010
- By:
- Publication type:
- Report
Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 114, n. 3, p. 479, doi. 10.1007/s10549-008-0018-1
- By:
- Publication type:
- Article
Detection of TP53 and PIK3CA Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer Diagnosis.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 8, p. 1183, doi. 10.3390/jcm8081183
- By:
- Publication type:
- Article
Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Overexpression of c-erbB-2 in epithelial ovarian cancer. Prognostic value and relationship with response to chemotherapy.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Ruptured Abdominal Aortic Aneurysms.
- Published in:
- Vascular Surgery, 1994, v. 28, n. 7, p. 459, doi. 10.1177/153857449402800703
- By:
- Publication type:
- Article
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00351-4
- By:
- Publication type:
- Article
RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Outcome Differences Between Patients With Node-Negative Breast Cancer Classified According to the St. Gallen Risk Categories.
- Published in:
- Clinical Breast Cancer, 2009, v. 9, n. 4, p. 231, doi. 10.3816/CBC.2009.n.039
- By:
- Publication type:
- Article